Jun 15 2010
ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L), is offering for sale a portfolio of three US issued patents relating to a condensed perfusion circuit for cardiac bypass. The technology of the portfolio should be of interest to any medical device company currently working in the cardiac surgery sector, or looking to establish a leading position in this growing field. This portfolio is a strong addition to ICAP Ocean Tomo's growing Bio/Life Sciences practice.
Developed by Dr. Kevin McCusker and Dr. Venkataramana Vijay, this portfolio represents the future of cardio-perfusion circuits. The assets describe a novel dual-function (open/closed) condensed perfusion circuit that effectively reduces the cost of cardiac bypass or other open chest surgeries while improving the surgical process by providing several key advantages over existing methods and devices. The patented condensed perfusion circuit can run either in an open or closed configuration with a priming volume of less than 800 mL, leading to decreases in morbidity, the cost of post-surgery care, and the amount of blood needed during surgery.
"With historic rises in chronic cardiovascular diseases upon us, these assets enter the cardiac bypass market at a crucial time," said Dean Becker, ICAP Ocean Tomo CEO. "The market is clearly heading in this direction. Estimated future revenues generated by this portfolio make this opportunity extremely valuable for any company operating or looking to operate within this space."
SOURCE ICAP Ocean Tomo
AI-powered MRI predicts outcomes in prostate cancer